EMA validates marketing authorisation applications for AstraZeneca, Daiichi Sankyo datopotamab deruxtecan in lung, breast cancer Ruchika Sharma6 March 2024 3:25 PM ISTCambridge: The European Medicines Agency (EMA) has validated two marketing authorisation applications (MAAs) for AstraZeneca and Daiichi Sankyo’s...
Exploring the genome of male breast cancer Anshika Mishra5 March 2024 8:30 PM ISTAccording to a study conducted by researchers at Weill Cornell Medicine, distinct genetic alterations in the tumour genome of male breast cancer could...
SII boosts cervical cancer shots supply ahead of govt mass drive Ruchika Sharma4 March 2024 2:43 PM ISTPoonawalla expects the vaccine to be "substantially, probably eight times, cheaper" when supplied to the government.
New microbiome discovery may enhance immunotherapy for various rare cancers Anshika Mishra4 March 2024 1:00 AM ISTResearchers from the Wellcome Sanger Institute, the Olivia Newton-John Cancer Research Institute in Australia have identified specific strains of...
Johnson and Johnson gets USFDA approval for Rybrevant, chemotherapy combo for lung cancer treatment Ruchika Sharma2 March 2024 2:33 PM ISTRaritan: Johnson & Johnson has announced that following a priority review, the U.S. Food and Drug Administration (FDA) has approved RYBREVANT...
Early Colorectal Cancer Screening may Reduce Cancer-Specific Mortality: JAMA Jacinthlyn Sylvia1 March 2024 4:30 AM ISTA recent study published in the Journal of American Medical Association revealed that early invitation to Colorectal cancer (CRC) screening could...
Simple hysterectomy non-inferior to radical hysterectomy for pelvic recurrence in women with low-risk cervical cancer: NEJM Medha Baranwal29 Feb 2024 6:45 PM ISTCanada: A recent study published in the New England Journal of Medicine compared simple versus radical hysterectomy in women with low-risk cervical...
Bayer gets USFDA Breakthrough Therapy designation for BAY 2927088 for non-small cell lung cancer harboring HER2 activating mutations Ruchika Sharma29 Feb 2024 1:30 PM ISTBAY 2927088 was derived from Bayer's long-standing strategic research alliance with the Broad Institute of MIT and Harvard in Cambridge, MA, USA.
Risk-reducing mastectomy may lower breast cancer mortality, finds study Dr. Kamal Kant Kohli28 Feb 2024 8:00 PM ISTA study co-led by Professor Kelly Metcalfe of the Lawrence Bloomberg Faculty of Nursing, and researchers at the Familial Breast Cancer Research Unit...
Annual breast cancer screening beginning at 40 saves lives Dr. Kamal Kant Kohli28 Feb 2024 1:45 AM ISTAnnual breast cancer screening beginning at age 40 and continuing to at least age 79 results in the highest reduction in mortality with minimal risks,...
Merck gets positive EMA Committee opinion for Keytruda, chemotherapy combo for Resectable non-small cell lung cancer Ruchika Sharma26 Feb 2024 2:30 PM ISTRahway: Merck, known as MSD outside of the United States and Canada, has announced that the European Medicines Agency's Committee for Medicinal...
Bristol Myers Squibb, Immunocore Holdings ink pact to evaluate IMC-F106C, nivolumab combo in registrational Phase 3 first-line advanced cutaneous melanoma trial Ruchika Sharma25 Feb 2024 2:00 PM ISTOxfordshire: Immunocore Holdings plc, a commercial-stage biotechnology company has announced that it has entered into a clinical trial...
